Partner Hospitals

Founded in 1844, it was the first Western medicine hospital after the opening of Shanghai port. It is equipped with advanced medical equipment including dual-source photon-counting CT, PET-CT, PET-MR, Da Vinci surgical robot, X-ray stereotactic radiotherapy system, TomoTherapy system, linear accelerator (LA), 320-row 640-slice ultra-speed spiral CT, hybrid operating room system and telemedicine teaching system. The hospital has 2,750 authorized beds. Annual outpatient and emergency visits reach 7.4584 million, inpatient admissions 268,200, and inpatient surgeries 134,000.

Founded in 1964, it is a benchmark for cancer diagnosis and treatment in South China. Annual outpatient and emergency visits reach 2.558 million, and annual inpatient admissions are 222,000. Its medical volume ranks among the top of national oncology-specialized hospitals. It boasts leading medical technologies and an Asia-class radiotherapy center with top-tier hardware and software. Minimally invasive robotic surgeries are performed in multiple specialties. The hospital maintains cooperation with The University of Texas MD Anderson Cancer Center, which ranks No.1 among oncology centers in the United States.

Founded in 1904. The hospital registers more than 5.3 million annual outpatient and emergency visits, over 180,000 annual inpatient admissions, and more than 120,000 annual inpatient operations. The leading specialties including Orthopedics and Endocrinology and Metabolism enjoy nationally top-tier medical capabilities. The cure rates for complex trauma, hand and foot microsurgery, and refractory endocrine diseases rank among the highest in China.

Founded in 1869, the hospital has set national benchmarks including the “Hangzhou Protocol” for transcatheter heart valve replacement, minimally invasive complex cataract surgery, standardized diagnosis and treatment of colorectal tumors, and mass severe trauma rescue. The perioperative survival rate of pediatric liver transplantation is at the internationally leading level.

Founded in 1947, it enjoys a high reputation in organ transplantation, infectious diseases, hematological diseases, kidney diseases, urinary system diseases and clinical pharmacy. It is one of China’s medical centers with the most complete range of large organ transplantation procedures.

Founded in 1892, it has reached leading domestic and international standards in many fields, such as adult living donor liver transplantation, early diagnosis and treatment of lung cancer, cardiac interventional therapy, neurosurgery and functional neurosurgery, integrated traditional Chinese and Western medicine for severe pancreatitis, and allogeneic combined larynx-trachea-thyroid transplantation.

Founded in 1958. It takes a leading position in China in the fields of early tumor screening, precision radiotherapy, targeted therapy and immunotherapy. Equipped with advanced facilities such as PET-CT, CyberKnife and proton therapy system as well as a multidisciplinary consultation system. The hospital has 72 departments and 626 physicians. Annual outpatient visits exceed 1 million, with more than 30,000 surgeries performed each year.

Founded in 1937. Its clinical capabilities in the fields of heart, liver, kidney, lung, digestive tract and panvascular diseases are at the top domestic and world-advanced level. The hospital is fully equipped with world-class diagnostic and therapeutic equipment including Da Vinci surgical robots, 3.0T high-field MRI, PET-CT, high-end DSA interventional systems and precision radiotherapy devices. More than 90 MDT teams have been established. Annual outpatient and emergency visits exceed 6.1 million, inpatient admissions over 280,000, and inpatient surgeries more than 210,000.